Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Read more about Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression.
Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer. Read more about Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer.
Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin. Read more about Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin.
Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer. Read more about Safety and biological activity of repeated doses of recombinant human Flt3 ligand in patients with bone scan-negative hormone-refractory prostate cancer.
Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors. Read more about Phase I trial of temozolomide and protracted irinotecan in pediatric patients with refractory solid tumors.
BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Read more about BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.
Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Read more about Elevated expression of inhibitor of apoptosis proteins in prostate cancer.
Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. Read more about Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling. Read more about Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling.
Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells. Read more about Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells.
